To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Estrogen Receptor Positive Tumor|HER2-positive Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Palbociclib|DRUG: Letrozole|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: ETOP IBCSG Partners Foundation
Collaborators: Pfizer|Hoffmann-La Roche